The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular edema and macular edema following retinal vein occlusion.

Australian researchers have identified an association between nocturnal hypoxia and neovascular age-related degeneration (nAMD). 1 Acting on this realization could prevent nAMD in some patients, ...

Panelists discuss how aflibercept 8 mg demonstrates improved durability and maintenance of visual gains compared with 2-mg dosing, potentially reducing treatment burden while maintaining a similar ...

The application was refiled following a December 20, 2024, meeting between the US Food and Drug Administration (FDA) and Astellas. The US Food and Drug Administration (FDA) has accepted the revised ...

Several pharmaceutical companies have announced new appointments of executives and board members as they prepare for growth in 2025. With the start of 2025, many companies have evaluated the skills ...

Panelists discuss how successful port delivery system (PDS) implantation requires careful patient selection and meticulous surgical technique to minimize complications like vitreous hemorrhage and ...

A recent cohort study revealed low adoption of FDA-approved AI-based diabetic retinopathy detection, with less than 5% of diabetic patients receiving ophthalmic imaging. Researchers emphasize the need ...

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding that you may have missed. With the busy holiday season and the winter ...

Turkish researchers reported that optical coherence tomography (OCT) and OCT angiography (OCTA) provide objective supplementary measurements of the retinal nerve fiber layer (RNFL), macular ganglion ...

The Korea Institute of Science and Technology (KIST) has entered into a technology transfer agreement with Huons BioPharma for the development and commercialization of a peptide treatment for dry ...

Jacques Gilbert has been appointed Chief Strategy and Business Development Officer for Topcon Healthcare Inc. According to the company, Jacques will lead the development and execution of Topcon ...

The ArMaDa clinical trial is currently being performed at 13 leading retinal surgery centers across the U.S. Dosing in the OCU410 ArMaDa clinical trial will be completed in early 2025 and the Company ...